• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对古迪亚瑟姆镇直接观察短程治疗自我管理情况的评估。

An evaluation of the self administration of DDS in Gudiyatham Taluk.

作者信息

Jesudasan K, George B, Chacko C J, Taylor P M, Kurian P V, Job C K

出版信息

Lepr India. 1976 Oct;48(4 Suppl):668-76.

PMID:1026802
Abstract

This study using the dapsone/creatinine (D/C) ratio was undertaken to find out how many of the patients attending the Village Clinics were actually taking the DDS tablets. The Urine D/C ratio was estimated in 35 patients who were receiving a supervised daily dosage of either 50 or 100 mgs of DDS. The D/C ratio was also estimated in 100 out patients who were on either 50 or 100 mgs of dapsone. It was determined that 72% of this group had taken DDS in the previous 24 hours. It was also seen that the 55 patients who were receiving 100 mgs of DDS had taken 79.3% of their dapsone dosage, and the 45 patients receiving 50 mgs of DDS had taken 96% of their dosage.

摘要

本研究采用氨苯砜/肌酐(D/C)比值,以查明在乡村诊所就诊的患者中实际服用氨苯砜片的人数。对35名接受每日50毫克或100毫克氨苯砜监督剂量治疗的患者进行了尿D/C比值测定。还对100名服用50毫克或100毫克氨苯砜的门诊患者进行了D/C比值测定。结果确定,该组中有72%的患者在过去24小时内服用了氨苯砜。还发现,接受100毫克氨苯砜治疗的55名患者服用了其氨苯砜剂量的79.3%,而接受50毫克氨苯砜治疗的45名患者服用了其剂量的96%。

相似文献

1
An evaluation of the self administration of DDS in Gudiyatham Taluk.对古迪亚瑟姆镇直接观察短程治疗自我管理情况的评估。
Lepr India. 1976 Oct;48(4 Suppl):668-76.
2
Monitoring self administration of dapsone by patients.监测患者自行服用氨苯砜的情况。
Lepr India. 1977 Jul;49(3):364-71.
3
Operational study to monitor the regularity of dapsone intake by leprosy out-patients.
Lepr India. 1983 Jul;55(3):521-7.
4
Monitoring the regularity of self administration of dapsone by leprosy patients.
Lepr India. 1982 Oct;54(4):664-70.
5
Assessment of self administration of dapsone in urine by out-patients attending field clinics.对在现场诊所就诊的门诊患者尿液中氨苯砜自我给药情况的评估。
Lepr India. 1980 Apr;52(2):249-51.
6
Paper spot test and DDS/creatinine ratios in relation to treatment taken by leprosy patients.麻风病患者的纸斑试验及DDS/肌酐比值与所接受治疗的关系
Lepr India. 1983 Apr;55(2):231-6.
7
Regularity of dapsone intake by leprosy patients attending urban treatment centre.
Lepr India. 1977 Apr;49(2):207-15.
8
DDS-resistant infection among leprosy patients in the population of Gudiyatham Taluk, South India. Part 3. Prevalence, incidence, risk factors, and interpretation of mouse foot pad test results.印度南部古迪亚瑟姆乡人群中麻风患者的耐二氨二苯砜感染。第3部分。患病率、发病率、风险因素及小鼠足垫试验结果解读
Int J Lepr Other Mycobact Dis. 1983 Sep;51(3):366-73.
9
Dapsone drug compliance study among leprosy patients: a comparison between qualitative and quantitative methods.麻风病患者中氨苯砜药物依从性研究:定性与定量方法的比较
Indian J Lepr. 1989 Jul;61(3):373-8.
10
Results of long-term domiciliary dapsone (DDS) monotherapy for lepromatous leprosy in Gudiyatham Taluk, South India.
Int J Lepr Other Mycobact Dis. 1983 Sep;51(3):385-6.